Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYouGov Share News (YOU)

Share Price Information for YouGov (YOU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 875.00
Bid: 870.00
Ask: 880.00
Change: -32.00 (-3.63%)
Spread: 10.00 (1.149%)
Open: 885.00
High: 850.00
Low: 850.00
Prev. Close: 882.00
YOU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European trust in AstraZeneca vaccine falls, opinion poll says

Mon, 22nd Mar 2021 00:01

BRUSSELS, March 22 (Reuters) - Fewer Europeans trust the
AstraZeneca COVID-19 vaccine after several countries
reported side-effects, such as blood clots, an opinion poll by
YouGov showed on Monday, even though scientific studies have
found it is safe and effective.

An increased number of French, German, Italian and Spanish
adults said they considered the vaccine unsafe, YouGov found,
although faith in other vaccines by Pfizer Inc and
Moderna Inc was unaffected.

"Not only have we seen considerable rises in those who
consider it unsafe in the last two weeks in Europe, the
AstraZeneca vaccine continues to be seen as substantially less
safe than its Pfizer and Moderna counterparts," lead data
journalist at YouGov Matt Smith said in a statement.

Sixty-one percent of French adults surveyed said the vaccine
was unsafe, a rise of 18 percentage points compared to February,
YouGov said.

Just over half of German adults surveyed said they thought
the vaccine was unsafe, a rise of 15 percentage points compared
to February, while 43% of Italians had serious doubts, an
increase of almost a third.

Spain showed a similar increase to Italy in the level of
concern, YouGov said. Only in Britain was trust in the vaccine
stable.

While the European Medicines Agency (EMA) has investigated
reports of unusual blood disorders in recipients of the
AstraZeneca vaccine, it said last week the benefits outweighed
the risks and continues to recommend its use.

This month a series of European countries, including France,
Germany and Italy halted its use after Denmark and Norway
reporting isolated cases of bleeding, blood clots and a low
platelet count.

That was the latest setback in the European Union's troubled
rollout of vaccines that has been dogged by delays.

As EU nations face a third wave of infections and their
vaccination campaigns move more slowly than those of Britain and
the United States, health experts have chided EU leaders for
poor communication and said the vaccine AstraZeneca developed in
partnership with Britain's Oxford University is safe.

YouGov pollster surveyed 1,672 British adults, 2,024
Germans, 1,022 French, 1,016 Italians, 1050 Spaniards, 1,004
Danes, and 1,017 Swedes between March 12 and March 18 2021.
(Reporting by Robin Emmott; editing by Barbara Lewis)

More News
9 Dec 2021 09:27

LONDON BROKER RATINGS: Morgan Stanley upgrades Rio Tinto and Polymetal

LONDON BROKER RATINGS: Morgan Stanley upgrades Rio Tinto and Polymetal

Read more
9 Dec 2021 08:14

LONDON BRIEFING: Go-Ahead shares to be suspended as faces rail fine

LONDON BRIEFING: Go-Ahead shares to be suspended as faces rail fine

Read more
6 Dec 2021 14:48

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
30 Nov 2021 16:26

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
26 Nov 2021 17:17

UPDATE 1-UK inflation expectations fall for first time in 6 months -Citi/YouGov

(Adds comments and background)LONDON, Nov 26 (Reuters) - Expectations among the British public for inflation over the next year fell for the first time in six months in November and were steady looking further ahead, according to a survey by Citi ...

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
29 Oct 2021 13:00

UPDATE 2-Sterling pushed down by dollar strength; investors look ahead to BoE

(Updates prices, adds dollar move and UK-France dispute update)By Elizabeth HowcroftLONDON, Oct 29(Reuters) - Sterling dropped against a stronger dollar on Friday but recovered some of the previous session's losses against the euro and was set for ...

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
20 Oct 2021 08:06

LONDON BRIEFING: "Temporary respite" in UK inflation puts BoE in bind

LONDON BRIEFING: "Temporary respite" in UK inflation puts BoE in bind

Read more
19 Oct 2021 14:45

YouGov in 'strong position' as revenue, profits rise

(Sharecast News) - YouGov reported revenue growth of 11% in its full-year results on Tuesday, to £169m, with underlying growth coming in at 18% for the 12 months ended 31 July, on the back of "strong delivery" in its second half.

Read more
19 Oct 2021 14:02

IN BRIEF: YouGov annual growth in line with internal expectations

IN BRIEF: YouGov annual growth in line with internal expectations

Read more
13 Oct 2021 09:58

LONDON BROKER RATINGS: UBS cuts Informa to Sell; M&S gets upgrade

LONDON BROKER RATINGS: UBS cuts Informa to Sell; M&S gets upgrade

Read more
12 Oct 2021 16:06

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
12 Oct 2021 10:25

YouGov profit to surge on rising revenue; buys tech firm Rezonence

YouGov profit to surge on rising revenue; buys tech firm Rezonence

Read more
12 Oct 2021 08:31

YouGov delays FY preliminary results, acquires advertising firm Rezonence

(Sharecast News) - Research and data analytics group YouGov said on Tuesday that due to "unforeseen circumstances" arising late in the audit process, it now requires additional time to finalise its full-year preliminary results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.